ClinicalTrials.gg
Sign In
RecruitingNCT07898657Updated Oct 27, 2026

Effect of an Electromagnetic Trainer on Gait and Balance Recovery After Stroke

An interventional study of Electromagnetic trainer and Standard medical rehabilitation in Stroke, sponsored by Karaganda Medical University. Recruiting at 2 sites in Kazakhstan. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Karaganda Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2026, registered Oct 2026).
  • Started May 2026; still recruiting 5 months later.
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to evaluate the effectiveness of an electromagnetic trainer in improving lower limb motor function, gait, and balance in patients after cerebral stroke. The study will include 80 adult patients with a first-ever cerebral stroke who are undergoing medical rehabilitation. Participants will be randomly allocated to two parallel groups. The control group will receive standard medical rehabilitation, while the intervention group will receive standard rehabilitation combined with motor training using an electromagnetic trainer. Clinical and functional assessments will include neurological status, functional independence, gait and balance, lower limb motor function, muscle tone, range of motion, and psycho-emotional status. The study is expected to determine whether the addition of electromagnetic motor training provides greater improvement in functional outcomes compared with standard rehabilitation alone.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke rehabilitation
  • Electromechanical rehabilitation device
  • Lower limb motor function
  • Balance
  • Gait
03

In context

Stroke

7,448 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's planned enrollment of 80 is above the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Karaganda Medical University is the lead sponsor of 12 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. First-ever confirmed cerebral stroke.
  2. Adults aged 18 to 75 years.
  3. Acute or early subacute period after stroke following early verticalization.
  4. Clear consciousness.
  5. Presence of lower-limb motor impairment.
  6. MMSE score ≥25.
  7. No rheumatologic conditions, including contractures or severe pain that may interfere with rehabilitation.
  8. No acute or decompensated chronic internal diseases.
  9. Provision of written informed consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Impaired or unclear consciousness.
  2. Recurrent stroke.
  3. Absence of lower-limb motor impairment.
  4. Cognitive impairment (MMSE \<25).
  5. Rheumatologic conditions, including contractures or severe pain that may interfere with rehabilitation.
  6. Acute or decompensated chronic internal diseases.
  7. Refusal to participate or withdrawal of informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    standart rehabilitation alone

    Participants will receive standard medical rehabilitation after stroke.

    Other: Standard medical rehabilitation

  • Experimental
    standart rehabilitation plus trainer

    Participants will receive standard medical rehabilitation combined with motor training using an electromagnetic trainer.

    Device: Electromagnetic trainer · Other: Standard medical rehabilitation

Interventions

  • DeviceElectromagnetic trainer

    Motor training using an electromagnetic trainer to improve lower limb motor function, gait, and balance after cerebral stroke. The intervention is provided in addition to standard medical rehabilitation.

  • OtherStandard medical rehabilitation

    \- Standard medical rehabilitation provided to participants after cerebral stroke according to the clinical rehabilitation program.

06

What researchers measure

Primary outcomes

  1. Berg Balance Scale (BBS)

    Change in Berg Balance Scale (BBS) score from baseline to the end of rehabilitation. The BBS ranges from 0 to 56 points, with higher scores indicating better balance.

    Time frame: From baseline to the end of the rehabilitation course (approximately 10 days).

Secondary outcomes

  1. Change in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitation

    Change in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitation. The total score ranges from 0 to 28 points, with higher scores indicating better gait and balance performance.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

  2. Change in Timed Up and Go (TUG) test time from baseline to the end of rehabilitation

    Change in the time required to complete the Timed Up and Go (TUG) test from baseline to the end of rehabilitation. Time is measured in seconds; lower times indicate better functional mobility.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

  3. Fugl-Meyer Assessment - Lower Extremity, Section E (0-28 points)

    Change in lower-extremity motor function assessed using Section E of the Fugl-Meyer Assessment. The score ranges from 0 to 28 points, with higher scores indicating better motor function.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

  4. Change in National Institutes of Health Stroke Scale (NIHSS) score from baseline to the end of rehabilitation

    Change in neurological impairment assessed using the National Institutes of Health Stroke Scale (NIHSS) from baseline to the end of rehabilitation. The total score ranges from 0 to 42 points, with higher scores indicating more severe neurological impairment.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

  5. Change in Modified Ashworth Scale score from baseline to the end of rehabilitation

    Change in muscle tone assessed using the Modified Ashworth Scale (MAS) from baseline to the end of rehabilitation. The scale grades resistance to passive movement from 0 to 4, with an additional grade of 1+, where applicable. Higher grades indicate greater muscle tone and spasticity.

    Time frame: At rehabilitation admission (baseline) and at discharge from rehabilitation (approximately 10 days after baseline).

  6. Change in Hospital Anxiety and Depression Scale (HADS) score from baseline to the end of rehabilitation

    Change in anxiety and depressive symptoms assessed using the Hospital Anxiety and Depression Scale (HADS) from baseline to the end of rehabilitation. The scale consists of two subscales: anxiety (HADS-A) and depression (HADS-D), each ranging from 0 to 21 points. Higher scores indicate greater severity of anxiety or depressive symptoms.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

  7. Change in Barthel Index score from baseline to the end of rehabilitation

    Change in functional independence assessed using the Barthel Index from baseline to the end of rehabilitation. The total score ranges from 0 to 100 points, with higher scores indicating greater independence in activities of daily living.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

Other outcomes

  1. Change in lower limb joint range of motion from baseline to the end of rehabilitation

    Assessment of changes in range of motion of the lower limb joints using goniometry. Hip and knee flexion and extension, and ankle dorsiflexion and plantarflexion are measured in degrees.

    Time frame: Baseline to end of rehabilitation (approximately 10 days)

07

Study locations

2 of 2 sites recruiting
  • Akzhan Clinic
    Karaganda, Qaraghandy Oblysy, Kazakhstan
    • Inna Bolshakova · Contact · I.Malysheva@qmu.kz · +77773512504
    • Inna A Bolshakova · Principal investigator
    Recruiting
  • Multidisciplinary Hospital named after Professor H. Zh. Makazhanov
    Karaganda, Qaraghandy Oblysy, Kazakhstan
    • Inna Bolshakova · Contact · I.Malysheva@qmu.kz · +77773512504
    • Inna Bolshakova · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Aug 2027, 15 months after the start.

Of 2,859 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's planned 15 months is below that.

Counting every sponsor, half of 2,988 studies reached it within 23 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Oct 27, 2026
StartActual
May 12, 2026
Primary completionEst.
Aug 2027
CompletionEst.
Aug 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07898657
Lead sponsor
Karaganda Medical University
Responsible party
Sponsor
First posted
Oct 27, 2026
Start date
May 12, 2026
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Inna A Bolshakova
Contact
I.Malysheva@qmu.kz
+77773512504
Tokzhan Toktarovna Kispayeva, Doctor of Medical Sciences
study chair · Karaganda Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Stroke →

Other studies from this sponsor

Karaganda Medical University

Start the discussion